Feedback PLC Feedback retains industry standard certification
November 22 2018 - 6:59AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
22 November 2018
Feedback plc
Feedback Medical Ltd retains international medical devices
industry standard certification following independent audit
Cambridge, 22 November 2018: Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the specialist medical imaging technology
company, announces that its operating company, Feedback Medical
Ltd, has retained its ISO 13485:2016 certification for the fourth
consecutive year.
ISO 13485:2016 is the internationally recognised 'Medical
Devices Quality Management' standard specifying that organisations
demonstrate their ability to provide medical devices and related
services that consistently meet customer and regulatory
requirements.
Feedback Medical Ltd's continued compliance with this standard
illustrates the importance that it places on the quality of its
products and customer support. The certification was awarded
following a surveillance audit by independent compliance
specialists SGS UK Ltd.
Dr Stephen Brown, Feedback Medical Ltd's Quality and Regulatory
Compliance Director, said:
"This successful audit demonstrates our dedication to ensuring
that our products are safe, effective and reliable. We strive to
meet and exceed our customer's expectations and international
quality standards, in the face of ongoing change within the
regulatory landscape of our target markets."
- ENDS -
For further information, please contact:
Feedback plc +44 (0)1954 718072
Alastair Riddell, Executive Chairman IR@fbk.com
Lindsay Melvin, CFO
Instinctif Partners +44 (0)20 7457 2020
Rozi Morris/ Deborah Bell/ Phillip Marriage feedbackplc@instinctif.com
Notes to editors
About Feedback plc
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer. Feedback Medical works
with customers globally from headquarters in the internationally
renowned scientific hub of Cambridge, UK. Its proprietary
technologies are TexRAD(R) , the quantitative texture analysis tool
and Cadran, a picture archiving communication system (PACS). For
more information, see www.fbk.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRABTBTTMBATBAP
(END) Dow Jones Newswires
November 22, 2018 07:59 ET (12:59 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Apr 2024 to May 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From May 2023 to May 2024